Cargando…
Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling
In platelets, the nitric oxide (NO)–induced cGMP response is indicative of a highly regulated interplay of cGMP formation and cGMP degradation. Recently, we showed that within the NO-induced cGMP response in human platelets, activation and phosphorylation of phosphodiesterase type 5 (PDE5) occurred....
Autores principales: | Mullershausen, Florian, Friebe, Andreas, Feil, Robert, Thompson, W. Joseph, Hofmann, Franz, Koesling, Doris |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2173359/ https://www.ncbi.nlm.nih.gov/pubmed/12604588 http://dx.doi.org/10.1083/jcb.200211041 |
Ejemplares similares
-
PDE2, a component of the NO/cGMP signalling in the hippocampus
por: Schönle, Isabel, et al.
Publicado: (2011) -
Rapid nitric oxide–induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme
por: Mullershausen, Florian, et al.
Publicado: (2001) -
PDE5 says NO to cGMP
por: LeBrasseur, Nicole
Publicado: (2003) -
cGMP kinase I regulates glucagon release
por: Leiss, Veronika, et al.
Publicado: (2009) -
cGMP kinase I, cardiac hypertrophy and PDE inhibition
por: Patrucco, Enrico, et al.
Publicado: (2011)